Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
18.45
+0.01 (+0.05%)
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Other Filings
< Previous
1
2
3
4
5
6
7
8
9
...
49
50
Next >
Form 6-K
Source:
SEC/Edgar
May 14, 2017
Form 6-K
Source:
SEC/Edgar
May 10, 2017
Form 6-K
Source:
SEC/Edgar
May 10, 2017
Form 6-K
Source:
SEC/Edgar
April 25, 2017
Form 6-K
Source:
SEC/Edgar
April 25, 2017
Form 6-K
Source:
SEC/Edgar
April 19, 2017
Form 6-K
Source:
SEC/Edgar
April 18, 2017
Form 6-K
Source:
SEC/Edgar
April 12, 2017
Form 6-K
Source:
SEC/Edgar
April 05, 2017
Form 6-K
Source:
SEC/Edgar
April 02, 2017
Form 6-K
Source:
SEC/Edgar
March 15, 2017
Form 6-K
Source:
SEC/Edgar
March 12, 2017
Form 6-K
Source:
SEC/Edgar
March 05, 2017
Form 6-K
Source:
SEC/Edgar
February 15, 2017
Form 20-F
Source:
SEC/Edgar
February 14, 2017
Form SC 13G/A
Source:
SEC/Edgar
February 13, 2017
Form 6-K
Source:
SEC/Edgar
February 12, 2017
Form 6-K
Source:
SEC/Edgar
February 05, 2017
Form 6-K
Source:
SEC/Edgar
February 01, 2017
Form 6-K
Source:
SEC/Edgar
January 31, 2017
Form 6-K
Source:
SEC/Edgar
January 30, 2017
Form 6-K
Source:
SEC/Edgar
January 29, 2017
Form 6-K
Source:
SEC/Edgar
January 25, 2017
Form 6-K
Source:
SEC/Edgar
January 17, 2017
Form 6-K
Source:
SEC/Edgar
January 08, 2017
Form 6-K
Source:
SEC/Edgar
January 05, 2017
Form 6-K
Source:
SEC/Edgar
January 05, 2017
Form 6-K
Source:
SEC/Edgar
January 04, 2017
Form 6-K
Source:
SEC/Edgar
December 21, 2016
Form 6-K
Source:
SEC/Edgar
December 06, 2016
< Previous
1
2
3
4
5
6
7
8
9
...
49
50
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.